Nautilus is a different kind of science magazine. We deliver big-picture science by reporting on a single monthly topic from multiple perspectives. Read a new chapter in the story every Thursday.
Obits | Post Bulletin postbulletin.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from postbulletin.com Daily Mail and Mail on Sunday newspapers.
The Art Of Coaching And Mentoring In Life Sciences Manufacturing
Edgar Guerzon
Tunnell Consulting’s Edgar Guerzon has spent most of his 36-year career in the biopharmaceutical industry on, or very close to, the manufacturing floor. Consulting with start-ups and established players in pharmaceuticals and life sciences, he has provided a full range of services to these companies, including FDA Remediation, Compliance, GMP Validation, Project Management, and Lean Six Sigma. Invariably, he finds himself being asked to go the “extra step” and coach and mentor groups of manufacturing staff on industry expectations and best practices. And being a person who loves to teach, he has embraced the opportunity to pass his knowledge along. Here are some of his views on this “art” and how it provides real value during a client engagement.
The Pew Charitable Trusts
In March, nearly 40 individuals from across the country will meet with their legislators to urge Congress to take bipartisan action to prioritize the battle against antibiotic resistance: a looming global health threat that threatens the future of modern medicine. As part of The Pew Charitable Trusts’ Stand Up to Superbugs initiative, this year’s ambassadors include health care professionals, public health officials, scientists, farmers and ranchers, veterinarians, superbug survivors, and people who have lost loved ones to an antibiotic-resistant infection. They will meet virtually with federal agency leaders and members of Congress to share their superbug stories and expertise, and urge increased commitment and momentum to preserve the effectiveness of existing antibiotics and develop urgently needed new ones.